Researchers from NAU, Washington Tackling an Elusive Valley Fever Vaccine

CWRU Researchers Developing Treatment for Drug-Resistant Fungus with $3M-Plus Grant from National Institutes of Health

Publish or Event Date
Research Institution
Case Western Reserve University
Short Title
CWRU Researchers Developing Treatment for Drug-Resistant Fungus with $3M-Plus Grant from National Institutes of Health
Content Coordinator
Content Manager

Gut Microbes Disturbed by COVID-19 Infection, Especially with Antibiotics

Penn Scientists Develop 20-Subtype mRNA Flu Vaccine to Protect Against Future Flu Pandemics

Publish or Event Date
Research Institution
University of Pennsylvania Perelman School of Medicine
Short Title
Penn Scientists Develop 20-Subtype mRNA Flu Vaccine to Protect Against Future Flu Pandemics
Content Coordinator
Content Manager

Notice of Special Interest (NOSI)—Administrative Supplements to Prepare Data Assets for Infectious and Immune-mediated Diseases for Inclusion into the NIAID Data Ecosystem

The purpose of this NOSI is to highlight interest in supporting supplemental funding applications for award recipients currently funded by participating NIH Institutes and Centers to prepare data assets relevant for infectious- and immune-mediated disease research for inclusion in the NIAID Data Ecosystem. Research may include studies that strive to generate a better understanding of mechanisms for the prevention, diagnosis, and treatment of infectious- and immune mediated diseases.

Group A Streptococcal Infections Biology and Genetics

Through research, health experts have learned that there are more than 120 different strains of group A streptococci bacteria, each producing its own unique proteins. Some of these proteins are responsible for specific GAS diseases. With the support of NIAID, scientists have determined the genetic sequence, or DNA code, for five strains of the group A streptococcus bacterium. By studying its genes, scientists can learn which proteins are responsible for virulence—crucial information that will lead to new and improved drugs and vaccines.

Ancient Disease has Potential to Regenerate Livers

Unusual Type of Antibody Shows Ultrapotent Activity Against Zika

SBU Lab Receives NIH Funding for Research on Preventing Future Pandemics

UAMS Using $2.4 Million NIH Grant to Study Bacterium that Causes Tickborne Relapsing Fever

Publish or Event Date
Research Institution
University of Arkansas for Medical Sciences
Short Title
UAMS Using $2.4 Million NIH Grant Study Bacterium Causes Tickborne Relapsing Fever
Content Coordinator
Content Manager